GrippeEspagneV1, Main, Exploration, bibRecord, 000320

Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.

Identifieur interne : 000320 ( Main/Exploration ); précédent : 000319; suivant : 000321

Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.

Auteurs : E. Cordero [Espagne] ; T. Aydillo ; M C Fari As ; J R Pa O-Pardo ; J. Pach N ; D. Viasus ; M. Riera ; F. L Pez-Medrano ; A. Payeras ; A. Moreno ; J. Rodríguez-Ba O ; J A Oteo ; J. Martínez-Montauti ; J. Torre-Cisneros ; F. Segura ; J. Carratalá

Source :

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [ 1435-4373 ] ; 2012.

RBID : pubmed:21792558

Descripteurs français

KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Analyse de survie (MeSH), Antiviraux (administration et posologie), Co-infection (épidémiologie), Espagne (MeSH), Femelle (MeSH), Grippe humaine (anatomopathologie), Grippe humaine (mortalité), Grippe humaine (traitement médicamenteux), Grippe humaine (virologie), Humains (MeSH), Immunosuppresseurs (administration et posologie), Jeune adulte (MeSH), Mâle (MeSH), Pneumopathie bactérienne (épidémiologie), Résultat thérapeutique (MeSH), Sous-type H1N1 du virus de la grippe A (isolement et purification), Sujet immunodéprimé (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Études de cohortes (MeSH), Études prospectives (MeSH).
MESH :
- administration et posologie : Antiviraux, Immunosuppresseurs.
- anatomopathologie : Grippe humaine.
- isolement et purification : Sous-type H1N1 du virus de la grippe A.
- mortalité : Grippe humaine.
- traitement médicamenteux : Grippe humaine.
- virologie : Grippe humaine.
- épidémiologie : Co-infection, Pneumopathie bactérienne.
- Adolescent, Adulte, Adulte d'âge moyen, Analyse de survie, Espagne, Femelle, Humains, Jeune adulte, Mâle, Résultat thérapeutique, Sujet immunodéprimé, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes, Études prospectives.
Wicri :
- geographic : Espagne.

English descriptors

KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Antiviral Agents (administration & dosage), Cohort Studies (MeSH), Coinfection (epidemiology), Female (MeSH), Humans (MeSH), Immunocompromised Host (MeSH), Immunosuppressive Agents (administration & dosage), Influenza A Virus, H1N1 Subtype (isolation & purification), Influenza, Human (drug therapy), Influenza, Human (mortality), Influenza, Human (pathology), Influenza, Human (virology), Male (MeSH), Middle Aged (MeSH), Pneumonia, Bacterial (epidemiology), Prospective Studies (MeSH), Spain (MeSH), Survival Analysis (MeSH), Treatment Outcome (MeSH), Young Adult (MeSH).
MESH :
- chemical , administration & dosage : Antiviral Agents, Immunosuppressive Agents.
- geographic : Spain.
- drug therapy : Influenza, Human.
- epidemiology : Coinfection, Pneumonia, Bacterial.
- isolation & purification : Influenza A Virus, H1N1 Subtype.
- mortality : Influenza, Human.
- pathology : Influenza, Human.
- virology : Influenza, Human.
- Adolescent, Adult, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Immunocompromised Host, Male, Middle Aged, Prospective Studies, Survival Analysis, Treatment Outcome, Young Adult.

Abstract

The purpose of this paper was to prospectively characterize the clinical manifestations and outcomes of confirmed influenza A 2009 (H1N1) virus infection in immunosuppressed patients with hospital admission and compare them with those of a general population. A multicenter prospective cohort study was carried out. All adult patients admitted to 13 hospitals in Spain with confirmed influenza A 2009 (H1N1) virus infection from June 12, 2009 to November 11, 2009 were included. Risk factors for complicated influenza infection were studied in immunosuppressed patients. Overall, 559 patients were included, of which 56 were immunosuppressed, nine with solid or hematological malignancies, 18 with solid-organ transplant recipients, 13 with corticosteroid therapy, and six with other types of immunosuppression. Clinical findings at diagnosis were similar in both groups. Nineteen immunosuppressed patients had pneumonia (33.9%). Immunosuppressed patients with pandemic influenza had bacterial co-infection more frequently (17.9% vs. 6.4%, p = 0.02), specifically, gram-negative bacilli and Staphylococcus aureus infections. Mortality was higher in immunosuppressed patients (7.1% vs. 1.8%, p < 0.05). The only modifiable risk factor of complicated influenza A 2009 (H1N1) was delayed antiviral therapy. In immunosuppressed patients, influenza A 2009 (H1N1) virus infection has higher mortality than in non-immunosuppressed individuals. Bacterial co-infection is common in complicated cases.

DOI: 10.1007/s10096-011-1346-3
PubMed: 21792558
PubMed Central: PMC7102055

Affiliations:

Espagne

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 00351
to stream Main, to step Curation: 000351

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.</title>
<author><name sortKey="Cordero, E" sort="Cordero, E" uniqKey="Cordero E" first="E" last="Cordero">E. Cordero</name>
<affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Unit, University Hospital Virgen del Rocío, Av. Manuel Siurot s/n, 41013, Sevilla, Spain. mariae.cordero.sspa@juntadeandalucia.es</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Infectious Diseases Unit, University Hospital Virgen del Rocío, Av. Manuel Siurot s/n, 41013, Sevilla</wicri:regionArea>
<wicri:noRegion>Sevilla</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Aydillo, T" sort="Aydillo, T" uniqKey="Aydillo T" first="T" last="Aydillo">T. Aydillo</name>
</author>
<author><name sortKey="Fari As, M C" sort="Fari As, M C" uniqKey="Fari As M" first="M C" last="Fari As">M C Fari As</name>
</author>
<author><name sortKey="Pa O Pardo, J R" sort="Pa O Pardo, J R" uniqKey="Pa O Pardo J" first="J R" last="Pa O-Pardo">J R Pa O-Pardo</name>
</author>
<author><name sortKey="Pach N, J" sort="Pach N, J" uniqKey="Pach N J" first="J" last="Pach N">J. Pach N</name>
</author>
<author><name sortKey="Viasus, D" sort="Viasus, D" uniqKey="Viasus D" first="D" last="Viasus">D. Viasus</name>
</author>
<author><name sortKey="Riera, M" sort="Riera, M" uniqKey="Riera M" first="M" last="Riera">M. Riera</name>
</author>
<author><name sortKey="L Pez Medrano, F" sort="L Pez Medrano, F" uniqKey="L Pez Medrano F" first="F" last="L Pez-Medrano">F. L Pez-Medrano</name>
</author>
<author><name sortKey="Payeras, A" sort="Payeras, A" uniqKey="Payeras A" first="A" last="Payeras">A. Payeras</name>
</author>
<author><name sortKey="Moreno, A" sort="Moreno, A" uniqKey="Moreno A" first="A" last="Moreno">A. Moreno</name>
</author>
<author><name sortKey="Rodriguez Ba O, J" sort="Rodriguez Ba O, J" uniqKey="Rodriguez Ba O J" first="J" last="Rodríguez-Ba O">J. Rodríguez-Ba O</name>
</author>
<author><name sortKey="Oteo, J A" sort="Oteo, J A" uniqKey="Oteo J" first="J A" last="Oteo">J A Oteo</name>
</author>
<author><name sortKey="Martinez Montauti, J" sort="Martinez Montauti, J" uniqKey="Martinez Montauti J" first="J" last="Martínez-Montauti">J. Martínez-Montauti</name>
</author>
<author><name sortKey="Torre Cisneros, J" sort="Torre Cisneros, J" uniqKey="Torre Cisneros J" first="J" last="Torre-Cisneros">J. Torre-Cisneros</name>
</author>
<author><name sortKey="Segura, F" sort="Segura, F" uniqKey="Segura F" first="F" last="Segura">F. Segura</name>
</author>
<author><name sortKey="Carratala, J" sort="Carratala, J" uniqKey="Carratala J" first="J" last="Carratalá">J. Carratalá</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:21792558</idno>
<idno type="pmid">21792558</idno>
<idno type="doi">10.1007/s10096-011-1346-3</idno>
<idno type="pmc">PMC7102055</idno>
<idno type="wicri:Area/Main/Corpus">00351</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00351</idno>
<idno type="wicri:Area/Main/Curation">000351</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000351</idno>
<idno type="wicri:Area/Main/Exploration">000351</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.</title>
<author><name sortKey="Cordero, E" sort="Cordero, E" uniqKey="Cordero E" first="E" last="Cordero">E. Cordero</name>
<affiliation wicri:level="1"><nlm:affiliation>Infectious Diseases Unit, University Hospital Virgen del Rocío, Av. Manuel Siurot s/n, 41013, Sevilla, Spain. mariae.cordero.sspa@juntadeandalucia.es</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Infectious Diseases Unit, University Hospital Virgen del Rocío, Av. Manuel Siurot s/n, 41013, Sevilla</wicri:regionArea>
<wicri:noRegion>Sevilla</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Aydillo, T" sort="Aydillo, T" uniqKey="Aydillo T" first="T" last="Aydillo">T. Aydillo</name>
</author>
<author><name sortKey="Fari As, M C" sort="Fari As, M C" uniqKey="Fari As M" first="M C" last="Fari As">M C Fari As</name>
</author>
<author><name sortKey="Pa O Pardo, J R" sort="Pa O Pardo, J R" uniqKey="Pa O Pardo J" first="J R" last="Pa O-Pardo">J R Pa O-Pardo</name>
</author>
<author><name sortKey="Pach N, J" sort="Pach N, J" uniqKey="Pach N J" first="J" last="Pach N">J. Pach N</name>
</author>
<author><name sortKey="Viasus, D" sort="Viasus, D" uniqKey="Viasus D" first="D" last="Viasus">D. Viasus</name>
</author>
<author><name sortKey="Riera, M" sort="Riera, M" uniqKey="Riera M" first="M" last="Riera">M. Riera</name>
</author>
<author><name sortKey="L Pez Medrano, F" sort="L Pez Medrano, F" uniqKey="L Pez Medrano F" first="F" last="L Pez-Medrano">F. L Pez-Medrano</name>
</author>
<author><name sortKey="Payeras, A" sort="Payeras, A" uniqKey="Payeras A" first="A" last="Payeras">A. Payeras</name>
</author>
<author><name sortKey="Moreno, A" sort="Moreno, A" uniqKey="Moreno A" first="A" last="Moreno">A. Moreno</name>
</author>
<author><name sortKey="Rodriguez Ba O, J" sort="Rodriguez Ba O, J" uniqKey="Rodriguez Ba O J" first="J" last="Rodríguez-Ba O">J. Rodríguez-Ba O</name>
</author>
<author><name sortKey="Oteo, J A" sort="Oteo, J A" uniqKey="Oteo J" first="J A" last="Oteo">J A Oteo</name>
</author>
<author><name sortKey="Martinez Montauti, J" sort="Martinez Montauti, J" uniqKey="Martinez Montauti J" first="J" last="Martínez-Montauti">J. Martínez-Montauti</name>
</author>
<author><name sortKey="Torre Cisneros, J" sort="Torre Cisneros, J" uniqKey="Torre Cisneros J" first="J" last="Torre-Cisneros">J. Torre-Cisneros</name>
</author>
<author><name sortKey="Segura, F" sort="Segura, F" uniqKey="Segura F" first="F" last="Segura">F. Segura</name>
</author>
<author><name sortKey="Carratala, J" sort="Carratala, J" uniqKey="Carratala J" first="J" last="Carratalá">J. Carratalá</name>
</author>
</analytic>
<series><title level="j">European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</title>
<idno type="eISSN">1435-4373</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Antiviral Agents (administration & dosage)</term>
<term>Cohort Studies (MeSH)</term>
<term>Coinfection (epidemiology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Immunocompromised Host (MeSH)</term>
<term>Immunosuppressive Agents (administration & dosage)</term>
<term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (mortality)</term>
<term>Influenza, Human (pathology)</term>
<term>Influenza, Human (virology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pneumonia, Bacterial (epidemiology)</term>
<term>Prospective Studies (MeSH)</term>
<term>Spain (MeSH)</term>
<term>Survival Analysis (MeSH)</term>
<term>Treatment Outcome (MeSH)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Analyse de survie (MeSH)</term>
<term>Antiviraux (administration et posologie)</term>
<term>Co-infection (épidémiologie)</term>
<term>Espagne (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (anatomopathologie)</term>
<term>Grippe humaine (mortalité)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Grippe humaine (virologie)</term>
<term>Humains (MeSH)</term>
<term>Immunosuppresseurs (administration et posologie)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Pneumopathie bactérienne (épidémiologie)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (isolement et purification)</term>
<term>Sujet immunodéprimé (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Études de cohortes (MeSH)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiviral Agents</term>
<term>Immunosuppressive Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antiviraux</term>
<term>Immunosuppresseurs</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coinfection</term>
<term>Pneumonia, Bacterial</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Co-infection</term>
<term>Pneumopathie bactérienne</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cohort Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Immunocompromised Host</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Survival Analysis</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Espagne</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Sujet immunodéprimé</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études de cohortes</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The purpose of this paper was to prospectively characterize the clinical manifestations and outcomes of confirmed influenza A 2009 (H1N1) virus infection in immunosuppressed patients with hospital admission and compare them with those of a general population. A multicenter prospective cohort study was carried out. All adult patients admitted to 13 hospitals in Spain with confirmed influenza A 2009 (H1N1) virus infection from June 12, 2009 to November 11, 2009 were included. Risk factors for complicated influenza infection were studied in immunosuppressed patients. Overall, 559 patients were included, of which 56 were immunosuppressed, nine with solid or hematological malignancies, 18 with solid-organ transplant recipients, 13 with corticosteroid therapy, and six with other types of immunosuppression. Clinical findings at diagnosis were similar in both groups. Nineteen immunosuppressed patients had pneumonia (33.9%). Immunosuppressed patients with pandemic influenza had bacterial co-infection more frequently (17.9% vs. 6.4%, p = 0.02), specifically, gram-negative bacilli and Staphylococcus aureus infections. Mortality was higher in immunosuppressed patients (7.1% vs. 1.8%, p < 0.05). The only modifiable risk factor of complicated influenza A 2009 (H1N1) was delayed antiviral therapy. In immunosuppressed patients, influenza A 2009 (H1N1) virus infection has higher mortality than in non-immunosuppressed individuals. Bacterial co-infection is common in complicated cases.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21792558</PMID>
<DateCompleted><Year>2012</Year>
<Month>07</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-4373</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>31</Volume>
<Issue>4</Issue>
<PubDate><Year>2012</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</Title>
<ISOAbbreviation>Eur. J. Clin. Microbiol. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.</ArticleTitle>
<Pagination><MedlinePgn>547-56</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10096-011-1346-3</ELocationID>
<Abstract><AbstractText>The purpose of this paper was to prospectively characterize the clinical manifestations and outcomes of confirmed influenza A 2009 (H1N1) virus infection in immunosuppressed patients with hospital admission and compare them with those of a general population. A multicenter prospective cohort study was carried out. All adult patients admitted to 13 hospitals in Spain with confirmed influenza A 2009 (H1N1) virus infection from June 12, 2009 to November 11, 2009 were included. Risk factors for complicated influenza infection were studied in immunosuppressed patients. Overall, 559 patients were included, of which 56 were immunosuppressed, nine with solid or hematological malignancies, 18 with solid-organ transplant recipients, 13 with corticosteroid therapy, and six with other types of immunosuppression. Clinical findings at diagnosis were similar in both groups. Nineteen immunosuppressed patients had pneumonia (33.9%). Immunosuppressed patients with pandemic influenza had bacterial co-infection more frequently (17.9% vs. 6.4%, p = 0.02), specifically, gram-negative bacilli and Staphylococcus aureus infections. Mortality was higher in immunosuppressed patients (7.1% vs. 1.8%, p < 0.05). The only modifiable risk factor of complicated influenza A 2009 (H1N1) was delayed antiviral therapy. In immunosuppressed patients, influenza A 2009 (H1N1) virus infection has higher mortality than in non-immunosuppressed individuals. Bacterial co-infection is common in complicated cases.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cordero</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Infectious Diseases Unit, University Hospital Virgen del Rocío, Av. Manuel Siurot s/n, 41013, Sevilla, Spain. mariae.cordero.sspa@juntadeandalucia.es</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Aydillo</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fariñas</LastName>
<ForeName>M C</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Paño-Pardo</LastName>
<ForeName>J R</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Pachón</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Viasus</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Riera</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>López-Medrano</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Payeras</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Moreno</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rodríguez-Baño</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Oteo</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Martínez-Montauti</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Torre-Cisneros</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Segura</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Carratalá</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><CollectiveName>Novel Influenza A(H1N1) Study Group of the SpanishNetwork for Research in Infectious Diseases (REIPI)</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2011</Year>
<Month>07</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA>
<NlmUniqueID>8804297</NlmUniqueID>
<ISSNLinking>0934-9723</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016867" MajorTopicYN="N">Immunocompromised Host</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018410" MajorTopicYN="N">Pneumonia, Bacterial</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<InvestigatorList><Investigator ValidYN="Y"><LastName>García-Cabrera</LastName>
<ForeName>Emilio</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>González-Fernández</LastName>
<ForeName>José Luis</ForeName>
<Initials>JL</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gutiérrez-Cuadra</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sanjuan</LastName>
<ForeName>María Victoria</ForeName>
<Initials>MV</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Parra</LastName>
<ForeName>José Antonio</ForeName>
<Initials>JA</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Martín-Quirós</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Romero-Gómez</LastName>
<ForeName>María</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ruíz-Carrascoso</LastName>
<ForeName>Guillermo</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Figueira</LastName>
<ForeName>Juan Carlos</ForeName>
<Initials>JC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Prados</LastName>
<ForeName>María Concepción</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Niubo</LastName>
<ForeName>Jordi</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Campins</LastName>
<ForeName>Antoni</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Aguado</LastName>
<ForeName>José María</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vila</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Villoslada</LastName>
<ForeName>Aroa</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>García-Gasalla</LastName>
<ForeName>Mercedes</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Linares</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Hoyo</LastName>
<ForeName>Irma</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Marcos</LastName>
<ForeName>María Ángeles</ForeName>
<Initials>MÁ</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pumarola</LastName>
<ForeName>Tomás</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>de Cueto</LastName>
<ForeName>Marina</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Domínguez</LastName>
<ForeName>Ángel</ForeName>
<Initials>Á</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gálvez</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Pérez-Martínez</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Blanco</LastName>
<ForeName>José R</ForeName>
<Initials>JR</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Sanz</LastName>
<ForeName>Mercedes</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Metola</LastName>
<ForeName>Luis</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ibarra</LastName>
<ForeName>Valvenera</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Ortega</LastName>
<ForeName>Lucía</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Lara</LastName>
<ForeName>Rosario</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Causse</LastName>
<ForeName>Manuel</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Gutiérrez-Aroca</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Vidal</LastName>
<ForeName>Elisa</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>Navarro</LastName>
<ForeName>Gemma</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y"><LastName>González</LastName>
<ForeName>Eva María</ForeName>
<Initials>EM</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year>
<Month>01</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2011</Year>
<Month>07</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>7</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21792558</ArticleId>
<ArticleId IdType="doi">10.1007/s10096-011-1346-3</ArticleId>
<ArticleId IdType="pmc">PMC7102055</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Respir Med. 2010 Jul;104(7):1050-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20181467</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biol Blood Marrow Transplant. 2011 Jan;17(1):147-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20637883</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2008 Apr 15;46(8):1323-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18444878</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Dec 24;361(26):2507-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20007555</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 May 8;58(17):467-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19444150</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CMAJ. 2010 Mar 9;182(4):349-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20159893</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2004 Nov 1;39(9):1300-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15494906</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2010 Aug;10(8):521-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20620116</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1935-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19815859</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 1993 Aug;17(2):244-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8399875</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 May 22;58(19):536-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19478723</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Transplant. 2002 Mar;2(3):287-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12096793</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2009 Aug 22;374(9690):605</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19700001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 Oct 2;58(38):1071-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19798021</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2003 Jan 1;36(1):1-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12491194</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biol Blood Marrow Transplant. 2011 Jul;17 (7):979-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20870025</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2007 Sep 1;110(5):1681-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17502457</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intern Med. 1988 Aug 1;109(3):203-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3389604</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Thorax. 2003 May;58(5):377-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12728155</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Jun 18;360(25):2605-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19423869</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Haematol. 2008 Nov;143(4):455-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18785968</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Pathol Lab Med. 2010 Feb;134(2):235-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20121613</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1997 Jan 23;336(4):243-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8995086</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2010 Mar 1;50(5):672-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20121412</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2010 Apr;60(4):257-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20138188</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
</list>
<tree><noCountry><name sortKey="Aydillo, T" sort="Aydillo, T" uniqKey="Aydillo T" first="T" last="Aydillo">T. Aydillo</name>
<name sortKey="Carratala, J" sort="Carratala, J" uniqKey="Carratala J" first="J" last="Carratalá">J. Carratalá</name>
<name sortKey="Fari As, M C" sort="Fari As, M C" uniqKey="Fari As M" first="M C" last="Fari As">M C Fari As</name>
<name sortKey="L Pez Medrano, F" sort="L Pez Medrano, F" uniqKey="L Pez Medrano F" first="F" last="L Pez-Medrano">F. L Pez-Medrano</name>
<name sortKey="Martinez Montauti, J" sort="Martinez Montauti, J" uniqKey="Martinez Montauti J" first="J" last="Martínez-Montauti">J. Martínez-Montauti</name>
<name sortKey="Moreno, A" sort="Moreno, A" uniqKey="Moreno A" first="A" last="Moreno">A. Moreno</name>
<name sortKey="Oteo, J A" sort="Oteo, J A" uniqKey="Oteo J" first="J A" last="Oteo">J A Oteo</name>
<name sortKey="Pa O Pardo, J R" sort="Pa O Pardo, J R" uniqKey="Pa O Pardo J" first="J R" last="Pa O-Pardo">J R Pa O-Pardo</name>
<name sortKey="Pach N, J" sort="Pach N, J" uniqKey="Pach N J" first="J" last="Pach N">J. Pach N</name>
<name sortKey="Payeras, A" sort="Payeras, A" uniqKey="Payeras A" first="A" last="Payeras">A. Payeras</name>
<name sortKey="Riera, M" sort="Riera, M" uniqKey="Riera M" first="M" last="Riera">M. Riera</name>
<name sortKey="Rodriguez Ba O, J" sort="Rodriguez Ba O, J" uniqKey="Rodriguez Ba O J" first="J" last="Rodríguez-Ba O">J. Rodríguez-Ba O</name>
<name sortKey="Segura, F" sort="Segura, F" uniqKey="Segura F" first="F" last="Segura">F. Segura</name>
<name sortKey="Torre Cisneros, J" sort="Torre Cisneros, J" uniqKey="Torre Cisneros J" first="J" last="Torre-Cisneros">J. Torre-Cisneros</name>
<name sortKey="Viasus, D" sort="Viasus, D" uniqKey="Viasus D" first="D" last="Viasus">D. Viasus</name>
</noCountry>
<country name="Espagne"><noRegion><name sortKey="Cordero, E" sort="Cordero, E" uniqKey="Cordero E" first="E" last="Cordero">E. Cordero</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000320 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000320 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21792558
   |texte=   Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21792558" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021

	Serveur d'exploration sur la grippe en Espagne
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe en Espagne

Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.

Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki